期刊文献+

胰岛素强化治疗对2型糖尿病患者血清脂联素的影响 被引量:2

Effect of Intensive Insulin Therapy on Serum Adiponectin Level in Type 2 Diabetic Patients
原文传递
导出
摘要 目的探讨胰岛素强化治疗对2型糖尿病(type 2diabetes mellitus,T2DM)患者血清脂联素(adiponectin,APN)的影响。方法 2007年7~12月,研究纳入连续使用胰岛素治疗至少3个月但血糖控制欠佳[6.5%≤糖化血红蛋白(hemoglobin A1c,HbA1c)≤11.0%]的T2DM患者40例,其中男18例,女22例;年龄29~69岁;平均诊断T2DM病史11年。治疗方案为进行16周的胰岛素强化治疗,血糖控制目标为空腹血糖≤7mmol/L,餐后2h血糖≤8mmol/L。分别于强化治疗前、强化治疗4周后及强化治疗16周后测定HbA1c以及血清APN水平。结果与强化治疗前相比,胰岛素治疗4周后空腹及三餐后2h血糖明显下降(P<0.05),但HbA1c和血清APN水平差异无统计学意义(P>0.05);强化16周后,HbA1c水平明显低于治疗前和治疗4周后且差异具有统计学意义(P<0.05),APN水平高于治疗前和治疗4周后且差异有统计学意义(P<0.05)。体质量指数在强化治疗16周后明显增加且与强化治疗前和强化治疗后4周相比差异具有统计学意义(P<0.05)。APN与空腹血糖(b=-0.225,P=0.013)、早餐后2h血糖(b=-0.229,P=0.012)呈负相关。结论胰岛素强化治疗可以提高T2DM患者血清APN水平。 Objective To investigate the effect of intensive insulin therapy on serum adiponectin(APN) level in patients with type 2 diabetes mellitus(T2DM).Methods Forty patients with T2DM who had undergone insulin therapy for at least three months but with their blood glucose poorly controlled [glycosylated hemoglobin Alc(HbA1c) level ranged from 6.5% to 10.0%] from July to December 2007 were enrolled in this study.There were 18 males and 22 females with their age ranged from 29 to 69 years.They had an average time of T2DM history of 11 years.Intensive insulin therapy was carried out for 16 weeks with a target of less than 7 mmol/L for fasting blood glucose and 8 mmol/L for postprandial blood glucose.HbA1c and serum adiponectin concentrations were detected at baseline,at week 4 after intensive therapy and at the end of the study.Results After 4 weeks of intensive blood glucose control,fasting and postprandial blood glucose levels decreased significantly(P0.05),but the HbA1c and serum APN concentrations did not reduce remarkably(P0.05).After 16 weeks of treatment,the level of HbA1c was significantly lower than those at baseline and 4 weeks after treatment(P0.05),and serum APN concentration increased significantly(P0.05),compared with those two time points.However,an evident increase of body mass index(BMI) was found while compared with BMI at baseline and 4 weeks after treatment(P0.05).The linear regression analysis indicated that APN was negatively associated with fasting blood glucose(b=-0.225,P=(0.013)) and blood glucose level 2 hours after breakfast(b=-0.229,P=0.012).Conclusion Intensive insulin therapy can improve serum adiponectin level in type-2 diabetic patients.
出处 《华西医学》 CAS 2011年第6期823-827,共5页 West China Medical Journal
关键词 2型糖尿病 脂联素 胰岛素强化治疗 Type 2 diabetes mellitus Adiponectin Intensive insulin therapy
  • 相关文献

参考文献25

  • 1The Diabetes Control and Complications Trial Researeh Group. The relationship of glycemic exposure (HbAlc) to the risk of development and progression of retinopathy in the diabetes control and complications trial [J]. Diabetes, 1995, 44 (8) : 968-983.
  • 2UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complicationsin overw'eight patients with type 2 diabetes (UKPDS 34)[J]. Lancet, 1998, 352(9131): 854-865.
  • 3ADVANCE Collaborative Group, Patel A, MacMahon S, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes[J]. N Engl J Med, 2008, 358 (24): 2560-2572.
  • 4Duckworth W, Abraira C, Moritz T, et al. Glucose control and vascular complications in veterans with type 2 diabetes [J]. N Engl J Med, 2009, 360(2) : 129-139.
  • 5ACCORD Study Group, Gerstein HC, Miller ME, el al. Long term effects of intensive glucose lowering on cardiovascular outcomes[J]. N EnglJ Med, 2011, 364(9): 818-828.
  • 6Ziegler D. Type 2 diabetes as an inflammatory cardiovascular disorder[J]. Curr Mol Med, 2005, 5(3): 309-322.
  • 7Weyer C, Funahashi T, Tanaka S, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia[J]. J Clin Endocrinol Metab, 2001, 86(5): 1930-1935.
  • 8Daimon M, Oizumi T, Saitoh T, et al. Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese Population: the Funagata study[J]. Diabetes Care, 2003, 26(7): 2015-2020.
  • 9Lindsay RS, Funahashi T, Hanson RI., el at. Adiponectin and development of type 2 diabetes in lhe Pima Indian population[J]. Lancet, 2002, 360(9326): 57-58.
  • 10Spranger J, Kroke A, Mohlig M, et al. Adiponectin and protection against type 2 diabetes mellitus[J]. Lancet, 2003, 361(9353): 226-228.

二级参考文献23

共引文献2

同被引文献29

  • 1杨华,龚海英,唐志浩.门诊胰岛素强化治疗初诊2型糖尿病疗效观察[J].广西医科大学学报,2007,24(5):768-769. 被引量:1
  • 2Biswas D, Vettriselvi V, Choudhury J, et al. Adiponectin genepoIy- morphism and its association with type 2 diabetes mellitus. Indian J Clin Biochem, 2011, 26(2):172-177.
  • 3Hilal Arikoglu, Hulya Ozdemir, Dudu Erkoc, et al. The Adiponectin variants contribute to the genetic background of type 2 diabetes in Turkish population. Gene, 2014, 534 (1):10-16.
  • 4Peters KE, Beilby J, Cadby G, et al. A comprehensive investigation of variants in genes encoding adiponectin (ADIPOQ) and its receptors (ADIPOR1/R2), and their association with serum adiponectin, type 2 diabetes, insulin resistance and the metabolic syndrome. BMC Med Genet, 2013(14):15.
  • 5Ostrowska L, Fiedorczuk J, Adamska E. Effect of diet and other factors on serum adiponectin concentrations in patients with type 2 diabetes. Rocz Panstw Zakl Hig, 2013, 64(1):61-66.
  • 6Owens DR. Clinical Evidence for the earlier initiation of insulin therapy in type 2 diabetes. Diabetes Technol Ther, 2013, 15(9): 776-785.
  • 7Van Beek M, Oravecz-Wilson KI, Delekta PC, et al. Bel 10 links saturated fat overnutrition with hepatocellular NF- K B activation and insulin resistance. Cell Rep, 2012, 1(5):444-452.
  • 8Holman RR, Farmer A J, Davies MJ, et al. Three-year efficacy of complex insulin regimens in type 2 diabetes. N Engl J Med, 2009, 361(18):1736-1747.
  • 9Dieuzeide G, Chuang LM, Almaghamsi A, et al. Safety and effectiveness of biphasic insulin aspart 30 in people with type2 diabetes switching from basal-bolus insulin regimens in the Alchieve study. Prim Care Diabetes, 2014, 8(2): 111-117.
  • 10Pei Haifeng, Qu Yah, Lu Xiaoyan. Cardiac-deriyed adiponectin induced by long-term insulin treatment ameliorates myocardial ischemia/reperfusion injury in type 1 diabetic mice via AMPK signaling. Basic Research in Cardiology, 2013, 108 (1):322.

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部